Craig Venter says that he has been "successful in is finding alternate ways to fund research," in the New York Times. A venture capitalist friend, Alan Walton, adds that "Craig is just a hopeless businessman." Venter began Synthetic Genomics as a way to fund his research in synthetic biology, and his work there has garnered attention — Venter notes he heard from the president and the pope on the same day after announcing the activation of a synthetic genome.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.